Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/qjmed/hcab077 http://scihub22266oqcxt.onion/10.1093/qjmed/hcab077 33871650!8083200!33871650     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33871650&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       QJM 2021 ; 114 (8): 596-597 Nephropedia Template TP {{tp|p=33871650|t=2021. Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis |pdf=|usr=}}{{33871650}} gab.com Text Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis JO: QJM http://www.kidney.de/pget.php?&tw=1&pmid=33871650 #FOAvip Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder affecting fatty acid oxidation. The myopathic form of the condition is the most common among adults and manifests itself with a high serum creatine kinase (CK) concentration. Triggers of very high CK concentrations include periods of fasting, infection, exercise, stress, and exposure to extreme temperatures. A 27-year-old man known to have CPT II deficiency presented feeling generally unwell after his COVID-19 vaccine. His CK concentration of 105,000 U/L and deranged liver function tests (ALT 300 U/L and AST 1496 U/L) were in keeping with rhabdomyolysis. His biochemical parameters and myopathy resolved with continuous intravenous dextrose 10% and a high carbohydrate diet. Caution should be exercised when administering vaccinations (including the COVID-19 vaccination) to this population. Clinicians should be wary for signs and symptoms of CPT II deficiency exacerbations and be vigilant in monitoring serum CK. Twit Text FOAVip Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis ????QJM http://www.kidney.de/pget.php?&tw=1&pmid=33871650 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33871650 #FOAvip English Wikipedia <ref>{{Cite pmid|33871650}}</ref> Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis #MMPMID33871650 Tan A; Stepien KM; Narayana STK QJM 2021[Nov]; 114 (8): 596-597 PMID33871650show ga Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder affecting fatty acid oxidation. The myopathic form of the condition is the most common among adults and manifests itself with a high serum creatine kinase (CK) concentration. Triggers of very high CK concentrations include periods of fasting, infection, exercise, stress, and exposure to extreme temperatures. A 27-year-old man known to have CPT II deficiency presented feeling generally unwell after his COVID-19 vaccine. His CK concentration of 105,000 U/L and deranged liver function tests (ALT 300 U/L and AST 1496 U/L) were in keeping with rhabdomyolysis. His biochemical parameters and myopathy resolved with continuous intravenous dextrose 10% and a high carbohydrate diet. Caution should be exercised when administering vaccinations (including the COVID-19 vaccination) to this population. Clinicians should be wary for signs and symptoms of CPT II deficiency exacerbations and be vigilant in monitoring serum CK. |*COVID-19[MESH] |*Rhabdomyolysis/etiology[MESH] |Carnitine O-Palmitoyltransferase/deficiency[MESH] |Humans[MESH] |Metabolism, Inborn Errors[MESH] |SARS-CoV-2[MESH]Carnitine palmitoyltransferase II deficiency and post-COVID vaccinatio(epmc).pdf DeepDyve Pubget Overpricing